The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...

"This technology gives us a powerful tool to detect prostate cancer earlier and more precisely,” said Dr. James Howard.

PET-CT is widely recommended in international clinical guidelines, including those of the European Association of Nuclear ...

Fortunately, a PET scan showed no evidence of cancer in Romano’s body. Still, her doctor recommended continuing with what she described as a “protocol,” which includes supplements, eight weeks of ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...

The ongoing Daro-PET study set out to evaluate the ability of the oral androgen receptor inhibitor darolutamide (Nubeqa) to ...

Construction and development specialist Seddon has completed enabling work to support the installation of UK-first Siemens Healthineers cancer imaging technology at a site on the Wirral.

"Milford Regional Medical Center is a highly respected community hospital with a strong commitment to clinical excellence," said Peter Ferrari, President of Shields Health. We are proud to collaborate ...

By Puyaan Singh and Sahil Pandey March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ...

Mary was sure something wasn’t right. For nearly a decade, the elementary school teacher and mother of two expressed concerns to doctors about itching, discomfort and blood in her stool, which were ...

It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...